| Title |
Glucosamine therapy for treating osteoarthritis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, April 2005
|
| DOI | 10.1002/14651858.cd002946.pub2 |
| Pubmed ID | |
| Authors |
Tanveer Towheed, Lara Maxwell, Tassos P Anastassiades, Beverley Shea, JB Houpt, Vivian Welch, Marc C Hochberg, George A Wells |
| Abstract |
Osteoarthritis (OA) is the most common form of arthritis, and it is often associated with significant disability and an impaired quality of life. |
X Demographics
The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 2 | 9% |
| United Kingdom | 2 | 9% |
| United States | 2 | 9% |
| Colombia | 2 | 9% |
| Australia | 1 | 5% |
| Argentina | 1 | 5% |
| Unknown | 12 | 55% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 19 | 86% |
| Practitioners (doctors, other healthcare professionals) | 3 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 528 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 4 | <1% |
| United States | 3 | <1% |
| Mexico | 2 | <1% |
| Korea, Republic of | 2 | <1% |
| Italy | 2 | <1% |
| South Africa | 1 | <1% |
| Portugal | 1 | <1% |
| Canada | 1 | <1% |
| Netherlands | 1 | <1% |
| Other | 2 | <1% |
| Unknown | 509 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 88 | 17% |
| Student > Master | 81 | 15% |
| Researcher | 56 | 11% |
| Other | 42 | 8% |
| Student > Ph. D. Student | 33 | 6% |
| Other | 107 | 20% |
| Unknown | 121 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 198 | 38% |
| Nursing and Health Professions | 40 | 8% |
| Agricultural and Biological Sciences | 36 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 22 | 4% |
| Biochemistry, Genetics and Molecular Biology | 16 | 3% |
| Other | 77 | 15% |
| Unknown | 139 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 116. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 November 2023.
All research outputs
#362,838
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#613
of 11,842 outputs
Outputs of similar age
#370
of 69,836 outputs
Outputs of similar age from Cochrane database of systematic reviews
#3
of 51 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 69,836 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.